RHEUMATOID NODULE DEVELOPMENT DURING TOCILIZUMAB-INDUCED RHEUMATOID ARTHRITIS REMISSION

Main Article Content

MARCO ROSSI
MAURO GALEAZZI
STEFANIA MANGANELLI

Abstract

At present the effect of monoclonal antibodies on rheumatoid nodules remains poorly understood. Several cases of development or enlargement of rheumatoid nodules in association with TNF-α inhibitors have been described in the medical literature. Recently three cases of regression of rheumatoid nodules following tocilizumab have been published. We describe a 55-year-old female patient with long-standing rheumatoid arthritis, who developed an olecranon nodule during tocilizumab-induced rheumatoid arthritis remission.

 

Keywords:
rheumatoid nodule, tocilizumab, rheumatoid arthritis, interleukin-6

Article Details

How to Cite
ROSSI, M., GALEAZZI, M., & MANGANELLI, S. (2017). RHEUMATOID NODULE DEVELOPMENT DURING TOCILIZUMAB-INDUCED RHEUMATOID ARTHRITIS REMISSION. Journal of Case Reports in Medical Science, 3(3), 59-61. Retrieved from https://www.ikprress.org/index.php/JOCRIMS/article/view/756
Section
Case Report